The Act Regarding Anonymized Medical Data to Contribute to R&D in the Medical Field ("Next Generation Medical Infrastructure Act") ...

The Japanese government has established the Agency for Medical Research and Development ("AMED") to promote medical research and development more efficiently and comprehensively.

Konaka, a Japanese men’s clothing retailer and Phiten, a Japanese holistic products company announced their collaboration and introduction of "Konaka X Phiten Dress Shirt" on July 5, 2011.

On June 15, 2020, the Japanese government implemented new regulations that designate the manufacture of pharmaceuticals for infectious diseases and the manufacture ...

Biotechnology venture company MYTECH of Kobe, Japan filed a patent application for early detection technology for cancer.

Due to the uncovering of clinical research misconduct in the past few years, the Clinical Research Act was enacted on April 7, 2017, and was promulgated on April 14, 2017.

Finnegan attorney Chiaki Kobayashi explores the complex landscape of genus claiming in biotechnology and pharmaceutical patents, examining doctrinal developments and practical drafting approaches. The article, edited by partner John D. Livingstone, provides strategic guidance for navigating means-plus-function claiming methodologies in life sciences intellectual property.

On June 9, 2025, biosimilar manufacturers Samsung Bioepis and Alvotech announced separate deals to expand their respective offerings in Japan and Europe.

The "Act Regarding Anonymized Medical Data to Contribute to R&D in the Medical Field" ("Next Generation Medical Infrastructure Act" or "Act") was enacted in Japan on April 28, 2017...

On October 21st, the Nikkei Keizai Shimbun reported on the outcome of a patent infringement law suit between Fuji Medical Devices and Family Inada.

Newsletter "Life Science Newsletter (January 2025)" has been published. Contents 1. Release of Summary Report on the Amendments to the Pharmaceuticals Act 1.1 Reinforcement of Quality Assurance.

On September 12, 2024, the Pharmaceutical and Medical Device System Subcommittee (the "Subcommittee") of the Japanese Ministry of Health, Labor and Welfare ("MHLW")...

本稿では、米国の連邦取引委員会...

On December 18, 2025, President Trump signed into law the BIOSECURE Act as part of the National Defense Authorization Act (NDAA), which is the U.S. Congress's annual defense policy bill.

The Japanese government is aware of the challenges in securing funds for drug development within Japan's biopharmaceutical startup ecosystem, especially compared to Europe and the United States.

医薬品特許紛争の早期解決メカニズムとして知られるパテントリンケージ制度が導入されてから2年が経過した。国家知識産権局（CNIPA）がこӗ

2025年12月18日、トランプ大統領は...

On January 15, 2020, the Ministry of Health, Labor and Welfare announced the ``Guidelines that distribution personnel should follow to improve the distribution of medical drugs''...

It's been five years since both the name and the content of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (the "Act")

On February 13, 2025, the Japan Fair Trade Commission ("JFTC") approved a commitment plan prepared by a marketing authorization holder of medical devices, etc.